Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Paris

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Journal of Neurochemistry|October 13, 2009
Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2Nikunj S Patel, Venkatarajan S Mathura, Corbin Bachmeier, et al.
Brain Injury|November 12, 2016
Chronic cerebrovascular abnormalities in a mouse model of repetitive mild traumatic brain injuryCillian E Lynch, Gogce Crynen, Scott Ferguson, et al.
Journal of Clinical and Translational Research|April 10, 2023
<i>Bacopa monnieri</i> supplementation has no effect on serum brain-derived neurotrophic factor levels but beneficially modulates nuclear factor kappa B and cyclic AMP response element-binding protein levels in healthy elderly subjectsAndrew P Keegan, Con Stough, Daniel Paris, et al.
Acta Neuropathologica Communications|September 8, 2017
Alzheimer's disease pathological lesions activate the spleen tyrosine kinaseJonas Elias Schweig, Hailan Yao, David Beaulieu-Abdelahad, et al.
Plos One|February 6, 2013
Amelioration of experimental autoimmune encephalomyelitis by anatabineDaniel Paris, David Beaulieu-Abdelahad, Myles Mullan, et al.
BMC Neuroscience|May 26, 2021
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's diseaseCharis Ringland, Jonas Elias Schweig, Maxwell Eisenbaum, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|October 17, 2008
Serum beta-amyloid correlates with neuropsychological impairmentCheryl A Luis, Laila Abdullah, Daniel Paris, et al.
Multiple Sclerosis and Related Disorders|May 6, 2022
Characterization of immune profile in an aging multiple sclerosis clinic populationAndrew P Keegan, Utsav Joshi, Laila Abdullah, et al.
Molecular Medicine (Cambridge, Mass.)|August 27, 2009
Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohortLaila Abdullah, Cheryl Luis, Daniel Paris, et al.
European Journal of Pharmacology|November 27, 2012
Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylationDaniel Paris, David Beaulieu-Abdelahad, Laila Abdullah, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Journal of Neurochemistry|October 13, 2009
Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2Nikunj S Patel, Venkatarajan S Mathura, Corbin Bachmeier, et al.
Brain Injury|November 12, 2016
Chronic cerebrovascular abnormalities in a mouse model of repetitive mild traumatic brain injuryCillian E Lynch, Gogce Crynen, Scott Ferguson, et al.
Journal of Clinical and Translational Research|April 10, 2023
<i>Bacopa monnieri</i> supplementation has no effect on serum brain-derived neurotrophic factor levels but beneficially modulates nuclear factor kappa B and cyclic AMP response element-binding protein levels in healthy elderly subjectsAndrew P Keegan, Con Stough, Daniel Paris, et al.
Acta Neuropathologica Communications|September 8, 2017
Alzheimer's disease pathological lesions activate the spleen tyrosine kinaseJonas Elias Schweig, Hailan Yao, David Beaulieu-Abdelahad, et al.
Plos One|February 6, 2013
Amelioration of experimental autoimmune encephalomyelitis by anatabineDaniel Paris, David Beaulieu-Abdelahad, Myles Mullan, et al.
BMC Neuroscience|May 26, 2021
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's diseaseCharis Ringland, Jonas Elias Schweig, Maxwell Eisenbaum, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|October 17, 2008
Serum beta-amyloid correlates with neuropsychological impairmentCheryl A Luis, Laila Abdullah, Daniel Paris, et al.
Multiple Sclerosis and Related Disorders|May 6, 2022
Characterization of immune profile in an aging multiple sclerosis clinic populationAndrew P Keegan, Utsav Joshi, Laila Abdullah, et al.
Molecular Medicine (Cambridge, Mass.)|August 27, 2009
Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohortLaila Abdullah, Cheryl Luis, Daniel Paris, et al.
European Journal of Pharmacology|November 27, 2012
Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylationDaniel Paris, David Beaulieu-Abdelahad, Laila Abdullah, et al.
Pageof 9